Abstract:Diabetes is a metabolic disease often characterized by elevated blood sugar levels, which is mainly treated through external injection of insulin. However, long-term insulin injection in patients will produce many adverse side effects such as hypoglycemia, subcutaneous fat atrophy and prolonged absorption, resulting in poor patient compliance. In this work, mesoporous silica (SBA-15) nanorods with large surface area (541.8 m 2 /g) were prepared via soft-templating method, which retained a large number of ordered mesoporous structures as the drug delivery carrier for insulin. Insulin-loaded mesoporous silica (SBA-15/INS) particle was obtained by solvent adsorption, which was then coated with hydroxypropyl methylcellulose phthalate (HP55) to form pH-sensitive mesoporous silica nanoparticles (HP55@SBA-15/INS). The surface area, structure and morphology of silica particles were addressed by BET, FTIR, XRD, SEM and TEM, indicating that SBA-15/INS and HP55@SBA-15/INS maintained the rod-like and ordered white strips structure similar to SBA-15. Also, insulin was found to be present in the mesoporous silica nanoparticles, with loading capacity and encapsulation efficiency reaching 25.5 % and 80.9 %, respectively. The vitro release results revealed that insulin release in the simulated gastric fluid (SGF, pH = 1.2) was significantly slower than that in the simulated intestinal fluid (SIF, pH = 7.4). Compared with SBA-15/INS, the release percentages in 15 % HP55@SBA-15/INS decreased 30 % in SGF, while it increased approximately 10 % in SIF. Kinetics analysis showed that the release process in HP55@SBA-15/INS was a Fick diffusion in both SGF and SIF and HP55 was degraded in SIF, resulting in accelerated insulin release. The cytotoxicity evaluation results showed that the cell viability of 4T1 after 24 h incubated with SBA-15 and 15 % HP55@SBA-15/INS was both approximately 100 %, demonstrating that the facile manufactured method has great potential to prepare macromolecular drug nanoparticle for oral release. Graphical abstract Fig.1 Schematic illustration of the fabrication of HP55@SBA-15/INS and its application in oral delivery of insulinThis paper reports a facile synthesis of pH-responsive mesoporous silica nanorod for oral delivery of insulin. As shown in Fig.1, insulin-loaded mesoporous silica (SBA-15/INS) particle was obtained by solvent adsorption, which was then coated with hydroxypropyl methylcellulose phthalate (HP55) to form pH-sensitive mesoporous silica nanoparticles (HP55@SBA-15/INS) via double emulsion solvent evaporation method. The insulin was found to be present in the mesoporous silica nanoparticles, with loading capacity and encapsulation efficiency reaching 25.5 % and 80.9 %, respectively. The HP55@SBA-15/INS nanoparticles show excellent release performance in simulated intestinal fluid (SIF, pH = 7.4) without observable cytotoxicity. And, the release process in HP55@SBA-15/INS is demonstrated to a Fick diffusion in SIF. More importantly, this synthesis method can be widely used to load other protein drug for oral delivery, which will produce various novel nanomedicines of different clinical applications. Download : Download high-res image (139KB) Download : Download full-size image

A Silica-Based Ph-Sensitive Nanomatrix System Improves the Oral Absorption and Efficacy of Incretin Hormone Glucagon-Like Peptide-1

Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy

Beneficial Properties for Insulin Absorption Using Superporous Hydrogel Containing Interpenetrating Polymer Network As Oral Delivery Vehicles

Overcoming Oral Insulin Delivery Barriers: Application of Cell Penetrating Peptide and Silica-Based Nanoporous Composites

Multifunctional Nanoparticles Enable Efficient Oral Delivery of Biomacromolecules Via Improving Payload Stability and Regulating the Transcytosis Pathway.

Bioinspired Zwitterionic Polyphosphoester Modified Porous Silicon Nanoparticles For Efficient Oral Insulin Delivery

Intestinal-Target and Glucose-Responsive Smart Hydrogel toward Oral Delivery System of Drug with Improved Insulin Utilization

Polymer Integrity Related Absorption Mechanism of Superporous Hydrogel Containing Interpenetrating Polymer Networks for Oral Delivery of Insulin.

Mucus- and pH-mediated controlled release of core-shell chitosan nanoparticles in the gastrointestinal tract for diabetes treatment

Enhancing Insulin Oral Absorption by Using Mucoadhesive Nanoparticles Loaded with LMWP-linked Insulin Conjugates.

pH-responsive mesoporous silica nanorod for high load and oral delivery of insulin

pH-Responsive and Mucoadhesive Nanoparticles for Enhanced Oral Insulin Delivery: The Effect of Hyaluronic Acid with Different Molecular Weights

Oral delivery of insulin with intelligent glucose-responsive switch for blood glucose regulation

Rational design of oral delivery nanosystems for hypoglycemic peptides

pH-sensitive chitosan-deoxycholic acid/alginate nanoparticles for oral insulin delivery

A nano-delivery system based on preventing degradation and promoting absorption to improve the oral bioavailability of insulin

Development and Characterization of a Glimepiride-Loaded Gelatin-Coated Mesoporous Hollow Silica Nanoparticle Formulation and Evaluation of Its Hypoglycemic Effect on Type-2 Diabetes Model Rats

Sulfobetaine modification of poly (D, L-lactide-co-glycolic acid) nanoparticles enhances mucus permeability and improves bioavailability of orally delivered liraglutide

Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery

Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin

A pH‐Triggered Self‐Unpacking Capsule Containing Zwitterionic Hydrogel‐Coated MOF Nanoparticles for Efficient Oral Exendin‐4 Delivery